Business Description
T2 Biosystems Inc
NAICS : 325413
SIC : 2835
ISIN : US89853L1044
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.32 | |||||
Equity-to-Asset | -0.81 | |||||
Debt-to-Equity | -1.77 | |||||
Debt-to-EBITDA | -1.13 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -28.3 | |||||
Beneish M-Score | -3.79 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -84.6 | |||||
3-Year EBITDA Growth Rate | 78 | |||||
3-Year EPS without NRI Growth Rate | 78.2 | |||||
3-Year FCF Growth Rate | 78.4 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
9-Day RSI | 39.45 | |||||
14-Day RSI | 42.18 | |||||
12-1 Month Momentum % | -48.82 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.45 | |||||
Quick Ratio | 0.36 | |||||
Cash Ratio | 0.28 | |||||
Days Inventory | 107.66 | |||||
Days Sales Outstanding | 75.04 | |||||
Days Payable | 44.08 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -39.9 | |||||
Shareholder Yield % | -147.72 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -113.58 | |||||
Operating Margin % | -655.54 | |||||
Net Margin % | -696.19 | |||||
FCF Margin % | -672.56 | |||||
ROA % | -137.37 | |||||
ROIC % | -109.13 | |||||
ROC (Joel Greenblatt) % | -383.98 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.2 | |||||
EV-to-EBIT | -1.49 | |||||
EV-to-Forward-EBIT | -1.67 | |||||
EV-to-EBITDA | -1.52 | |||||
EV-to-Revenue | 9.25 | |||||
EV-to-Forward-Revenue | 4.28 | |||||
EV-to-FCF | -1.38 | |||||
Earnings Yield (Greenblatt) % | -67.11 | |||||
FCF Yield % | -147.75 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
T2 Biosystems Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 6.673 | ||
EPS (TTM) (€) | -136.241 | ||
Beta | 29.77 | ||
Volatility % | 210.01 | ||
14-Day RSI | 42.18 | ||
14-Day ATR (€) | 0.000124 | ||
20-Day SMA (€) | 16 | ||
12-1 Month Momentum % | -48.82 | ||
52-Week Range (€) | 1 - 71.55 | ||
Shares Outstanding (Mil) | 8.79 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
T2 Biosystems Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
T2 Biosystems Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
T2 Biosystems Inc Frequently Asked Questions
What is T2 Biosystems Inc(FRA:3T2)'s stock price today?
When is next earnings date of T2 Biosystems Inc(FRA:3T2)?
Does T2 Biosystems Inc(FRA:3T2) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |